Scinai Immunotherapeutics SCNI
NASDAQ SCNI
$0.75 0.00 (-0.32%)
At close: Oct 19, 2026 · 4:00 PM EDT

Scinai Immunotherapeutics (SCNI) Receivables - Other (2022 - 2025)

Updated

Scinai Immunotherapeutics (SCNI) recorded Receivables - Other of $152,000 in Q4 2023, down 1.9% from $155,000 a year earlier.

Analysis

Scinai Immunotherapeutics (SCNI) Receivables - Other (2022 - 2025) Analysis & Trends

Starting with Q4 2021, Scinai Immunotherapeutics' Receivables - Other history includes 4 quarters.

  • Across earlier years, Receivables - Other came in at $155,000 in FY2022 (-52.5%) and $326,000 in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,109.83 Bn 1,078.42 Bn 19.71 Bn
2 Johnson & Johnson 610.61 Bn 529.14 Bn 17.26 Bn
3 AbbVie 500.66 Bn 473.77 Bn 12.70 Bn
4 Merck 354.64 Bn 309.02 Bn 12.21 Bn
5 Novartis Ag 291.14 Bn 255.13 Bn 11.24 Bn
6 Astrazeneca 254.18 Bn 227.87 Bn 12.86 Bn
7 Amgen 229.46 Bn 184.86 Bn 7.24 Bn
8 Gilead Sciences 190.33 Bn 164.53 Bn 6.22 Bn
9 Pfizer 167.92 Bn 114.57 Bn 10.94 Bn
10 Scinai Immunotherapeutics 170,024.89 -8.10 Mn -1.25 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -7.25 Mn
Dec 31, 2023 152,000.00
Jun 30, 2023 5.83 Mn
Dec 31, 2022 155,000.00
API Access

Scinai Immunotherapeutics Receivables - Other API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-other&ticker=SCNI&period=max&api_key=YOUR_API_KEY